Posted on 12/14/20
Virginia Leads Nation in COVID-19 App Use
Amid grim headlines related to the coronavirus, Virginia has one piece of bright news — the commonwealth leads the nation in the percentage of citizens who . . .
Posted on 12/14/20
Novavax Stock: Buy at the High?
Of all the rags to riches stories that the pandemic has fueled for drugmakers, few are as incredible as Novavax (NASDAQ:NVAX). Shares are up about 2,500% . . .
Posted on 12/11/20
CEL-SCI Closes of Its $14.65 Million Bought Deal
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company,announced the closing of the offering of 1,000,000 shares of its common stock at . . .
Posted on 12/10/20
Howard County General Hospital Receives State Accreditation to Train Community Health Workers
Howard County General Hospital received accreditation from the Maryland Department of Health to provide training and certification for community health workers. Community health workers connect people . . .
Posted on 12/10/20
Cities That Need the Most Initial Vaccinations Against COVID-19 – WalletHub Study
With frontline health care workers and other vulnerable populations like the elderly first in line to receive COVID-19 vaccinations, WalletHub today released its report on the . . .
Posted on 12/10/20
Cyrano Therapeutics Raises $12.8 Million
Cyrano Therapeutics, a clinical stage regenerative medicine company developing a novel intranasal therapy for smell and flavor restoration, has raised $12.8 million in a Series A . . .
Posted on 12/9/20
Why Novavax Stock Crushed It in November
What happenedShares of the COVID-19 vaccine developer Novavax (NASDAQ:NVAX) jumped by a healthy 73% during the month of November, according to data from S&P Global Market . . .
Posted on 12/8/20
Howard County General Hospital Holds ‘Managing Joint Pain’ Seminar
Howard County General Hospital will hold “Managing Joint Pain: When is it Time to Consider Joint Replacement?” virtually on Friday, Jan. 15, 2021, from noon to . . .
Posted on 12/8/20
Is Novavax Still a Buy After Jumping 3,000%?
Novavax (NASDAQ:NVAX) has jumped from a price of $4 a share back in January to $128 a share in December. That's a huge 3,000% gain for . . .
Posted on 12/7/20
Luminis Health Board Officers and New Appointments
Luminis Health announces board officers and new appointments for 2020-2021. Luminis Health Board of Trustees Gary Jobson, Chair Rene LaVigne, Vice Chair Leisa Russell, Vice Chair . . .
Posted on 12/7/20
Va. Expects 480,000 COVID Vaccine Doses by End of December
Virginia expects to receive 480,000 COVID-19 vaccine doses from Pfizer and Moderna by the end of December through the federal government’s Operation Warp Speed program, the . . .
Posted on 12/7/20
This COVID Vaccine Stock Has Been the Biggest Millionaire-Maker by Far
It's not surprising in the least that the stocks of several companies in the race to develop coronavirus vaccines have been sizzling hot so far this . . .
Posted on 12/4/20
Torrey Smith Joins Rose Health as Investor and Brand Ambassador to Promote Mental Health Resilience
Baltimore-based mental health technology startup, Rose Health, announced today that two-time Super Bowl champion and former Baltimore Raven, Torrey Smith, has become an investor in the . . .
Posted on 12/3/20
dancker’s New Logistical Facility Will Handle PPE for Healthcare Clients
Integrated interior solutions firm dancker has established a new logistical facility to support their healthcare clients’ COVID-19 planning and specifically help one of New Jersey’s largest . . .
Posted on 12/2/20
5 Baltimore-Washington Metro Area Researchers Receive Funding from American Lung Association
In an effort to save lives by improving lung health and preventing lung disease, the American Lung Association invests in promising lung health research. The organization . . .
Posted on 12/2/20
Altimmune: Needs To Focus On NasoVAX
SummaryAltimmune went up on unsubstantiated reports of Covid-19 work where its key asset is NasoVAX.The company also has interests in such diverse distractions like NASH, Hep . . .
Posted on 12/2/20
Altimmune: A COVID-19 Winner After All
SummaryShare price has recently stumbled due to results of the leading vaccines.Vaccine development timeline is way behind the leading vaccines.Altimmune COVID-19 treatments have some unique and . . .
Posted on 12/2/20
Novavax's Late-Stage COVID Vaccine Trial in U.S. Delayed Again: Should Investors Worry?
There's a maxim in business that it's best to underpromise and overdeliver. The idea is that it's always better to deliver a pleasant surprise than an . . .
Posted on 12/2/20
Is Novavax Stock a Buy?
The initial readouts of phase 3 trials for COVID-19 vaccines have been impressive. With efficacy rates as high as 95% (the average annual flu vaccine reaches . . .
Posted on 12/1/20
Va. COVID-19 Cases, Deaths Continue to Rise
COVID-19 rates continued to climb last week in Virginia, with an increase of 16,797 cases since Nov. 23, according to the Virginia Department of Health’s Nov. . . .
Posted on 12/1/20
Why Novavax Could Be a Bigger COVID Vaccine Winner Than Pfizer and Moderna
Some Americans could receive COVID-19 vaccinations before the end of 2020. Two coronavirus vaccines are in a prime position to win U.S. emergency use authorization (EUA) . . .
Posted on 11/30/20
Novavax Makes Progress, Is The Name A Discount Moderna?
The past few months I couldn't help but notice a sizable gap in the valuation of Moderna (MRNA) and Novavax (NVAX), two players in the race . . .
Posted on 11/30/20
Novavax Slips 6% After COVID-19 Vaccine Update
Novavax (NASDAQ:NVAX) provides an update on its COVID-19 vaccine program. NVX?CoV2373 is a stable, prefusion protein antigen derived from the genetic sequence of the SARS-CoV-2 coronavirus . . .
Posted on 11/24/20
‘SickleTini’ Benefits Sickle Cell Disease Association of America
Sickle Cell Disease Association of America will hold “SickleTini Winter Wonderland Happy Hour,” a virtual fundraising event on Giving Tuesday, Dec. 1, from 5:30 to 6:30 . . .
Posted on 11/24/20
RRD International Acquired By Uniphar
RRD International, a specialized product development company that provides strategic and operational support to biopharmaceutical companies and investors, announced today it has been acquired by Uniphar . . .
Washington DC
